Coverage
-
November 19, 2020
Teva Pharmaceuticals USA Inc. has agreed to pay nearly $2.6 million to wrap up a proposed ERISA class action accusing it of including unnecessarily costly investments in a 401(k) plan that also allegedly charged too much for administrative fees, according to documents filed in Pennsylvania federal court.
4 other articles on this case.
View all »